Neuren Pharmaceuticals Ltd
ASX:NEU
Neuren Pharmaceuticals Ltd
ASX:NEU
Price:
12.03
AUD
-2.51%
Market Closed
Market Cap:
AU$1.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
AU |
|
N
|
Nextcom Ltd
TASE:NXTM
|
IL |
|
Lexibook Linguistic Electronic System SA
PAR:ALLEX
|
FR |
|
Steico SE
XETRA:ST5
|
DE |
|
Zhicheng Technology Group Ltd
HKEX:8511
|
CN |
|
Qiagen NV
NYSE:QGEN
|
NL |
|
Amani Gold Ltd
ASX:ANL
|
AU |
|
P
|
PacRay International Holdings Ltd
HKEX:1010
|
HK |
|
Toyokumo Inc
TSE:4058
|
JP |
|
M
|
Maple Gold Mines Ltd
OTC:MGMLF
|
CA |
|
Star Housing Finance Ltd
BSE:539017
|
IN |
|
Saint Marc Holdings Co Ltd
TSE:3395
|
JP |
Balance Sheet
Balance Sheet Decomposition
Neuren Pharmaceuticals Ltd
Neuren Pharmaceuticals Ltd
Balance Sheet Decomposition is not available for
Neuren Pharmaceuticals Ltd
Neuren Pharmaceuticals Ltd
Balance Sheet
Neuren Pharmaceuticals Ltd
Neuren Pharmaceuticals Ltd
Currency: AUD
| Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||
| Cash & Cash Equivalents |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
8
|
4
|
3
|
2
|
4
|
14
|
24
|
37
|
40
|
17
|
3
|
4
|
|
| Cash |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
8
|
4
|
3
|
2
|
4
|
1
|
0
|
7
|
2
|
17
|
3
|
4
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
13
|
24
|
30
|
38
|
0
|
0
|
0
|
|
| Short-Term Investments |
1
|
0
|
12
|
9
|
1
|
1
|
3
|
1
|
7
|
5
|
23
|
13
|
12
|
2
|
3
|
20
|
0
|
0
|
0
|
0
|
211
|
219
|
292
|
|
| Total Receivables |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
14
|
175
|
27
|
|
| Accounts Receivables |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
173
|
19
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
2
|
7
|
|
| Other Current Assets |
0
|
1
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
11
|
2
|
0
|
0
|
2
|
2
|
4
|
2
|
10
|
|
| Total Current Assets |
2
|
2
|
13
|
10
|
1
|
2
|
5
|
2
|
8
|
5
|
26
|
22
|
17
|
6
|
16
|
27
|
14
|
25
|
40
|
43
|
247
|
399
|
332
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
11
|
10
|
9
|
13
|
7
|
5
|
4
|
4
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
1
|
10
|
11
|
|
| Total Assets |
3
N/A
|
13
+375%
|
23
+78%
|
20
-14%
|
15
-26%
|
8
-42%
|
10
+22%
|
6
-44%
|
11
+94%
|
9
-24%
|
26
+211%
|
22
-16%
|
17
-24%
|
6
-63%
|
18
+189%
|
27
+48%
|
14
-46%
|
25
+73%
|
40
+61%
|
43
+8%
|
248
+473%
|
410
+65%
|
343
-16%
|
|
| Liabilities | ||||||||||||||||||||||||
| Accounts Payable |
1
|
3
|
2
|
3
|
3
|
2
|
2
|
1
|
1
|
2
|
2
|
3
|
2
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Accrued Liabilities |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
3
|
1
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
39
|
43
|
2
|
|
| Total Current Liabilities |
1
|
4
|
3
|
3
|
7
|
3
|
3
|
2
|
2
|
2
|
2
|
3
|
3
|
2
|
2
|
2
|
1
|
1
|
1
|
2
|
43
|
46
|
4
|
|
| Long-Term Debt |
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
8
N/A
|
4
-44%
|
3
-27%
|
3
+12%
|
7
+107%
|
3
-58%
|
3
-5%
|
2
-23%
|
2
-24%
|
2
+23%
|
2
-7%
|
3
+51%
|
3
-11%
|
2
-19%
|
2
-22%
|
2
+25%
|
1
-72%
|
1
+35%
|
1
+7%
|
2
+109%
|
43
+2 448%
|
46
+7%
|
4
-90%
|
|
| Equity | ||||||||||||||||||||||||
| Common Stock |
0
|
19
|
39
|
45
|
47
|
57
|
56
|
53
|
61
|
64
|
102
|
104
|
112
|
113
|
121
|
126
|
126
|
146
|
168
|
168
|
173
|
165
|
135
|
|
| Retained Earnings |
5
|
11
|
19
|
28
|
40
|
53
|
49
|
49
|
52
|
58
|
77
|
74
|
87
|
98
|
94
|
91
|
102
|
111
|
118
|
115
|
43
|
185
|
216
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
14
|
13
|
|
| Total Equity |
5
N/A
|
9
N/A
|
20
+128%
|
16
-18%
|
8
-54%
|
6
-27%
|
7
+36%
|
4
-52%
|
10
+165%
|
7
-31%
|
25
+277%
|
19
-22%
|
14
-25%
|
4
-71%
|
16
+291%
|
25
+51%
|
14
-44%
|
24
+75%
|
39
+62%
|
42
+6%
|
205
+393%
|
364
+77%
|
338
-7%
|
|
| Total Liabilities & Equity |
3
N/A
|
13
+375%
|
23
+78%
|
20
-14%
|
15
-26%
|
8
-42%
|
10
+22%
|
6
-44%
|
11
+94%
|
9
-24%
|
26
+211%
|
22
-16%
|
17
-24%
|
6
-63%
|
18
+189%
|
27
+48%
|
14
-46%
|
25
+73%
|
40
+61%
|
43
+8%
|
248
+473%
|
410
+65%
|
343
-16%
|
|
| Shares Outstanding | ||||||||||||||||||||||||
| Common Shares Outstanding |
0
|
5
|
9
|
7
|
8
|
14
|
19
|
23
|
58
|
59
|
76
|
81
|
88
|
92
|
102
|
103
|
100
|
115
|
126
|
123
|
127
|
127
|
127
|
|
Switch to:
Switch to:
See Also
Discover More
